Medicare Enrolled
Dr. Theodore Manny, M.D.
Urology Physician · Greensboro, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Manny from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Manny?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Manny
Dr. Theodore Manny is an urology physician in Greensboro, NC, with 18 years of NPI registration. Based on federal Medicare data, Dr. Manny performed 9,999 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Manny received a total of $3,623 from 32 pharmaceutical and/or device companies across 177 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Manny is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 5% volume in NC
$3,623 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗9,999
Medicare services
Top 5% in NC for urology physician
Not available
Unique patients (not deduplicated)
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
5,300 | $0 | $0 |
| Denosumab injection (Prolia/Xgeva) | 2,160 | $19 | $27 |
| BCG treatment for bladder cancer | 900 | $2 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
354 | $86 | $224 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 276 | $135 | $614 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
217 | $2 | $8 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
170 | $3 | $13 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
95 | $7 | $41 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
68 | $57 | $150 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
52 | $178 | $750 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
46 | $24 | $115 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
41 | $100 | $370 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
34 | $41 | $230 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
33 | $189 | $906 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
31 | $20 | $67 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
31 | $9 | $67 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
30 | $38 | $288 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
29 | $19 | $51 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
18 | $66 | $395 |
| Lower leg neurostimulator electrode insertion A procedure to place an electrode in the lower leg for neurostimulation therapy. |
18 | $87 | $250 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
14 | $8 | $8 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
14 | $159 | $800 |
| CT scan of abdomen with and without contrast A CT scan of the abdomen performed both before and after the administration of contrast dye to provide detailed images of internal structures. |
14 | $126 | $872 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
14 | $95 | $345 |
| Injection, garamycin, gentamicin, up to 80 mg | 14 | $2 | $18 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
13 | $5 | $23 |
| Blood urea nitrogen test A blood test that measures the amount of urea nitrogen to assess kidney function. |
13 | $4 | $16 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$3,623
Total received (2018-2024)
Avg $518/year across 7 years
Top 39% in NC for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
177
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$357
2023
$252
2022
$799
2021
$284
2020
$124
2019
$995
2018
$813
Payments by company (2024)
Bayer Healthcare Pharmaceuticals Inc.
$143
PFIZER INC.
$100
ABBVIE INC.
$53
Astellas Pharma US Inc
$41
Ethicon US, LLC
$20
Top 3 companies account for 82.9% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$924
PFIZER INC.
$437
Myovant Sciences Inc.
$210
Bayer Healthcare Pharmaceuticals Inc.
$204
UroGen Pharma, Inc.
$194
Dendreon Pharmaceuticals LLC
$192
Augmenix, Inc.
$158
Bayer HealthCare Pharmaceuticals Inc.
$152
Endo Pharmaceuticals Inc.
$126
GENZYME CORPORATION
$120
Foundation Medicine, Inc.
$116
Intuitive Surgical, Inc.
$115
ABBVIE INC.
$102
NeoTract Inc.
$94
Amgen Inc.
$60
Boston Scientific Corporation
$60
AstraZeneca Pharmaceuticals LP
$48
AbbVie, Inc.
$42
Blue Earth Diagnostics Limited
$38
Ferring Pharmaceuticals Inc.
$35
Retrophin, Inc.
$30
Antares Pharma, Inc.
$30
Sumitomo Pharma America, Inc.
$21
Ethicon US, LLC
$20
BAXTER HEALTHCARE
$18
Merck Sharp & Dohme Corporation
$17
PROCEPT BioRobotics Corporation
$13
Allergan Inc.
$13
Avadel Specialty Pharmaceuticals, LLC
$12
Allergan, Inc.
$12
CONMED Corporation
$11
Travere Therapeutics, Inc.
$1
Top 3 companies account for 43.3% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AirSeal · Androgel · AquaBeam Robotic System · Axumin · BOTOX · BOTOX THERAPEUTIC · Da Vinci Surgical System · Enseal · FIRMAGON · FLOSEAL · FOUNDATIONONE · JELMYTO · JEVTANA · KEYTRUDA · LYNPARZA · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · PROVENGE · Prolia · REZUM · SpaceOAR · TOVIAZ · Thiola · UroLift · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
31
County median income
$66,027
Nearest hospital to ZIP centroid (approximate)
MOSES H. CONE MEMORIAL HOSPITAL, THE
3.3 mi
3.3 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Manny is a mixed practice specialist, with above-average Medicare volume (top 5% in NC), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Manny experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Manny performed 5,300 contrast dye for imaging (iodine-based) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Manny receive payments from pharmaceutical companies?
Yes. Dr. Manny received a total of $3,623 from 32 companies across 177 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Manny's costs compare to other urology physicians in Greensboro?
Dr. Manny's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Manny) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Greensboro
Browse urology physicians in Greensboro ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NC
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NC
Which NC urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Myovant Sciences Inc. Payments to Doctors
See all physicians who received payments from Myovant Sciences Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology